Epithalon (Ala-Glu-Asp-Gly): Telomerase Research and What Replicated

Epithalon is the one Khavinson bioregulator with current international replication. A citation-by-citation summary of the telomerase work, from the 2003 original through independent 2025 studies — including the correction notice.

epithalon epitalon bioregulator khavinson telomerase telomere Ala-Glu-Asp-Gly AEDG

Key Research Findings

  • Epithalon (Epitalon) is the tetrapeptide Ala-Glu-Asp-Gly (AEDG), C14H22N4O9, 390.35 g/mol.
  • It is the only Khavinson bioregulator with independent international replication, including 2025 studies.
  • The anchoring finding is telomerase induction and telomere elongation in human somatic cells (PMID 12937682).
  • A 2025 Biogerontology replication exists (PMID 40908429) — read it together with its published correction (PMID 41240216).
  • All human data are in cultured cells. Telomere length is a cellular endpoint, not a longevity outcome.
  • No controlled human programme exists, so no dosage figure is published.

Why Epithalon Is the Exception

Epithalon — also written Epitalon — is a synthetic tetrapeptide, Ala-Glu-Asp-Gly (AEDG), derived from the pineal preparation epithalamin. Its structure is confirmed: C14H22N4O9, 390.35 g/mol.

Among peptide bioregulators it occupies a distinct position. Most of the family has literature confined to one research group and one language. Epithalon does not: it has attracted independent work published in international journals as recently as 2025. That makes it the only member where the phrase "replicated" can be used with any care.

Research use only. Supplied for laboratory research. Not for human or veterinary use. No marketing authorisation exists and no therapeutic claim is made.

The Original Telomerase Finding

The claim that anchors everything else is that the peptide induced telomerase activity and telomere elongation in human somatic cells (Khavinson et al., Bull Exp Biol Med 2003, PMID 12937682). This is a cell-culture result in human somatic cells, not an organism-level outcome, and it should be read as such.

What Independent Work Has Since Reported

A 2025 study in Biogerontology reported that Epitalon increases telomere length in human cell lines, and attributed the effect to telomerase upregulation or alternative lengthening of telomeres (Al-Dulaimi et al., PMID 40908429). Scrupulousness requires noting that a correction to this paper was subsequently published (PMID 41240216); anyone building on it should read the correction alongside the original.

Separately, work in Life Sciences examined Epitalon-activated telomerase in bovine oocyte maturation and post-thaw embryo development (Ullah et al., 2025, PMID 39788414) — a different system entirely, which is what makes it informative rather than confirmatory.

A 2025 overview in International Journal of Molecular Sciences collects the bioactivity literature for the tetrapeptide (Araj et al., PMID 40141333) and is the most efficient entry point to the current state of the field.

Reading This Carefully

Telomere elongation is a cellular endpoint. It is not a longevity outcome, a health outcome, or evidence of either. Conflating the two is the most common error made with this compound.

Cell lines are not organisms. The human data are in cultured cells. The bovine work is in oocytes and embryos. Neither transfers to a whole organism without work that has not been done.

No controlled human programme exists. There is therefore no published amount for any population or context, and none is offered here.

Structure and Handling

  • Sequence. Ala-Glu-Asp-Gly (AEDG), tetrapeptide.
  • Formula. C14H22N4O9, 390.35 g/mol.
  • Form. Lyophilised powder, ≥98% purity, third-party certificate of analysis per batch.
  • Storage. Sealed vial at −20 °C, protected from light; reconstituted solution at 2–8 °C.
  • Reconstitution. Bacteriostatic water down the vial wall, never onto the powder cake. Do not shake. See the reconstitution calculator.

Vilon is the compound Epithalon is most often studied beside — the two appear together in the early gene-expression microarray work. For the family as a whole see the bioregulator overview.

Frequently Asked Questions

What is Epithalon?

Epithalon (also written Epitalon) is a synthetic tetrapeptide, Ala-Glu-Asp-Gly (AEDG), C14H22N4O9, 390.35 g/mol, derived from the pineal preparation epithalamin. It is the member of the Khavinson bioregulator family with the most substantial and most internationally replicated literature.

Does Epithalon actually affect telomeres?

Published cell-culture work reports telomerase induction and telomere elongation in human somatic cells (PMID 12937682, 2003), and a 2025 Biogerontology study reported increased telomere length in human cell lines (PMID 40908429). Note that a correction to the 2025 paper was subsequently published (PMID 41240216). These are cellular endpoints in cultured cells, not longevity or health outcomes.

Has Epithalon research been independently replicated?

It is the only member of this family where independent international work exists. Recent studies appear in Biogerontology and Life Sciences (2025), including work in bovine oocytes and embryos — a different system from the original human cell-culture work, which is what makes it informative rather than merely confirmatory.

Is there an established Epithalon dosage?

No. There is no controlled human programme, so no published figure exists for any population or context. Amounts circulating in non-clinical discussion are not traceable to controlled trials.

Does telomere elongation mean longer life?

No, and conflating the two is the most common error made with this compound. Telomere length is a cellular measurement. It is not a longevity outcome and the published work does not establish one.

References

  1. Khavinson VKh, Bondarev IE, Butyugov AA, Smirnova TD. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells Bulletin of Experimental Biology and Medicine (2003)
  2. Al-Dulaimi S, Matta C, Ball G, Denton P, Aziz A. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity Biogerontology (2025)
  3. Al-Dulaimi S, Matta C, Ball G, Denton P, Aziz A. Correction: Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity Biogerontology (2025)
  4. Ullah S, Kim J, Idrees M, Ryu S, Kong IK. Epitalon-activated telomerase enhance bovine oocyte maturation rate and post-thawed embryo development Life Sciences (2025)
  5. Araj SK, Szeleszczuk Ł. Overview of Epitalon — highly bioactive pineal tetrapeptide with promising properties International Journal of Molecular Sciences (2025)
Research Use Only: This content is intended for laboratory and scientific research purposes only. It is not intended for human use, medical advice, diagnosis, or treatment. All compounds discussed are for in vitro and preclinical research contexts.